Jorge Jacob, Jo Sha, Jeroen Jansen, Yuen Tsang, Luis Hernandez. "Model-based evaluation of clinical outcomes for ponatinib versus 2G TKIs in third-line chronic myeloid leukemia (CML)." Blood, 2025. doi:10.1182/blood-2025-7952